INO icon

Inovio Pharmaceuticals

113 hedge funds and large institutions have $26.2M invested in Inovio Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership:

less funds holding

Funds holding:

28% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 32

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

Holders
113
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$313K
Puts
$29K
Net Calls
Net Calls Change

Top Buyers

1 +$1.78M
2 +$1.23M
3 +$397K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$218K
5
Amundi
Amundi
France
+$120K

Top Sellers

1 -$2.12M
2 -$1.44M
3 -$1.01M
4
GC
GMT Capital
Georgia
-$589K
5
Two Sigma Investments
Two Sigma Investments
New York
-$255K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.1M
2
$3.72M
3
$2.01M
4
$1.94M
5
$1.46M
6
$1.38M
7
$586K
8
$553K
9
$452K
10
$444K
11
$283K
12
$236K
13
$230K
14
$215K
15
$214K
16
$181K
17
$170K
18
$168K
19
$148K
20
$120K
21
$116K
22
$77K
23
$76.5K
24
$74.5K
25
$71K